http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188098-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106188098-B |
| titleOfInvention | A kind of hydridization cancer therapy drug and preparation method and application |
| abstract | The invention discloses a kind of hydridization cancer therapy drug and preparation method and application, belong to pharmaceutical technology field.The structural formula of hydridization cancer therapy drug of the present invention is as shown in formula I：Wherein：X is selected from SCH 2 , CH=CH or (CH 2 ) 2 One kind in substituent；Y is selected from O or OCH 2 One kind in O；R 2 Selected from CN or ONO 2 In one kind.The binding affinity of of the invention designed and synthesis hydridization cancer therapy drug and XIAP BIR3 is stronger, promotes cancer cell-apoptosis, non-peptide feature is more obvious, can act on multiple target spots, play multi-efficiency. |
| priorityDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 201.